UnitedHealth Group Updates Business Outlook Ahead of Investor Conference
November 29 2021 - 04:15PM
Business Wire
UnitedHealth Group (NYSE: UNH) issued financial guidance ahead
of its annual Investor Conference which takes place on November 30,
beginning at 8 a.m. ET.
UnitedHealth Group revenues for 2021 are expected to be
approximately $287 billion, with net earnings of $17.80 to $17.95
per share and adjusted net earnings of $18.75 to $18.90 per share.
Adjusted net earnings only excludes the after-tax non-cash
amortization expense pertaining to acquisition-related intangible
assets.
UnitedHealth Group will also introduce its 2022 outlook, which
includes revenues of $317 billion to $320 billion, net earnings of
$20.20 to $20.70 per share, and adjusted net earnings of $21.10 to
$21.60 per share. Cash flows from operations are expected to range
from $23 billion to $24 billion in 2022.
The Company will stream the presentation and management
question-and-answer portion of this meeting on its Investor
Relations page at www.unitedhealthgroup.com. Meeting materials and
a replay of the conference will be available on the Investor
Relations page.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health care
company dedicated to helping people live healthier lives and
helping make the health system work better for everyone.
UnitedHealth Group offers a broad spectrum of products and services
through two distinct platforms: UnitedHealthcare, which provides
health care coverage and benefits services; and Optum, which
provides information and technology-enabled health services. For
more information, visit UnitedHealth Group at
www.unitedhealthgroup.com or follow @UnitedHealthGrp on
Twitter.
Non-GAAP Financial
Information
This news release presents non-GAAP financial information
provided as a complement to the results provided in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”). Adjusted net earnings exclude amortization
expense of approximately $1.25 and $1.20 per share and the related
tax impacts of $0.30 per share for years ending December 31, 2021
and 2022, respectively, pertaining to acquisition-related
intangible assets.
Forward-Looking
Statements
The statements, estimates, projections, guidance or outlook
contained in this document include “forward-looking” statements
which are intended to take advantage of the “safe harbor”
provisions of the federal securities law. The words “believe,”
“expect,” “intend,” “estimate,” “anticipate,” “forecast,”
“outlook,” “plan,” “project,” “should” and similar expressions
identify forward-looking statements. These statements may contain
information about financial prospects, economic conditions and
trends and involve risks and uncertainties. Actual results could
differ materially from those that management expects, depending on
the outcome of certain factors including: risks associated with
public health crises, large-scale medical emergencies and
pandemics, such as the COVID-19 pandemic; our ability to
effectively estimate, price for and manage medical costs; new or
changes in existing health care laws or regulations, or their
enforcement or application; the DOJ’s legal action relating to the
risk adjustment submission matter; our ability to maintain and
achieve improvement in quality scores impacting revenue; reductions
in revenue or delays to cash flows received under government
programs; changes in Medicare, the CMS star ratings program or the
application of risk adjustment data validation audits; failure to
maintain effective and efficient information systems or if our
technology products do not operate as intended; cyberattacks, other
privacy/data security incidents, or our failure to comply with
related regulations; risks and uncertainties associated with the
pharmacy benefits management industry; competitive pressures;
changes in or challenges to our public sector contract awards; our
ability to contract on competitive terms with physicians, hospitals
and other service providers; failure to attract, develop, retain,
and manage the succession of key employees and executives; the
impact of potential changes in tax laws and regulations (including
any increase in the U.S. income tax rate applicable to
corporations); failure to achieve targeted operating cost
productivity improvements; increases in costs and other liabilities
associated with litigation, government investigations, audits or
reviews; failure to manage successfully our strategic alliances or
complete or receive anticipated benefits of strategic transactions;
fluctuations in foreign currency exchange rates; downgrades in our
credit ratings; our investment portfolio performance; impairment of
our goodwill and intangible assets; and our ability to obtain
sufficient funds from our regulated subsidiaries or from external
financings to fund our obligations, maintain our debt to total
capital ratio at targeted levels, maintain our quarterly dividend
payment cycle, or continue repurchasing shares of our common stock.
This above list is not exhaustive. We discuss these matters, and
certain risks that may affect our business operations, financial
condition and results of operations more fully in our filings with
the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By
their nature, forward-looking statements are not guarantees of
future performance or results and are subject to risks,
uncertainties and assumptions that are difficult to predict or
quantify. Actual results may vary materially from expectations
expressed or implied in this document or any of our prior
communications. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. We do not undertake to update or revise any
forward-looking statements, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211129005670/en/
Brett Manderfeld Brett_Manderfeld@uhg.com 952-936-7216
Media: Matt Stearns Matt.Stearns@uhg.com 202-276-0085
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Feb 2024 to Mar 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Mar 2023 to Mar 2024